Position in ZTS
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$1,004,312
-$111,459 QoQ
Shares Held
8,496
-4.2% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2024
9 quarters on record
Voting authority
Sole 54.48446327683616.ToString("F0")%
Shared 0.ToString("F0")%
None 45.51553672316384.ToString("F0")%
Common Shares in ZTS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026KENNEDY CAPITAL MANAGEMENT LLC holds $41,938,404 across 7 Drug Manufacturers - Specialty & Generic names. ZTS ranks #5 (2.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ANIP |
Ani Pharmaceuticals Inc
|
293,996 | $22,608,292 | |
| 2 | NBIX |
Neurocrine Biosciences Inc
|
55,055 | $7,252,945 | |
| 3 | XERS |
Xeris Biopharma Holdings, Inc.
|
1,240,692 | $7,196,013 | |
| 4 | HROW |
Harrow, Inc.
|
74,256 | $2,618,266 | |
| 5 | ZTS |
Zoetis Inc.
This page
|
8,496 | $1,004,312 | |
| 6 | AMRX |
Amneal Pharmaceuticals, Inc.
|
50,977 | $633,644 | |
| 7 | VTRS |
Viatris Inc
|
46,257 | $624,932 |
All Filings in ZTS
Export CSV
9 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $1,004,312 | 8,496 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $1,115,771 | 8,868 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,302,101 | 8,899 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,710,771 | 10,970 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,998,192 | 12,136 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $2,133,405 | 13,094 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $2,071,614 | 10,603 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $2,884,190 | 16,637 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $883,276 | 5,220 | Shares | Sole | 2024-05-15 | |
| No filing history on record for this holder in this stock. | ||||||